ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Detail of the clinical trial

Title of the trial A Phase 2 Study to Evaluate the Efficacy and Tolerability of Debio 1562 in Combination with Rituximab in Patients with Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma and Other Forms of Non-Hodgkin?s Lymphoma
EudraCT number 2015-004061-87
Protocol number Debio1562-201
Sponsor Debiopharm International S.A., Forum "apres demain", Chemin Messidor 5-7, P.O. Box 5091, CH-1002 Lausanne, Switzerland
Indications Hemato-oncology
Diagnosis Non-Hodgkin´s Lymphoma
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Year of receiving the request to Institute (SÚKL) 2018
Date of approval by Institute (SÚKL) 16.7.2018
Date of approval by EC 18.7.2018
Date of initiation CT in ČR 10.9.2018
Date of ending CT in ČR 7.4.2021
Sites I. interní klinika - klinika hematologie, VFN Praha
FN Hradec Králové,IV. interní hematologická klinika,Sokolská 581,Hradec Králové,500 05
FN Královské Vinohrady,Interní hematologická klinika,Šrobárova 1150/50,Praha 10,100 34
FN Brno,Interní hematologická a onkologická klinika,Jihlavská 20,Brno,625 00

‹‹ Back to list